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Abstract
IgG-containing B cell antigen receptor (IgG-BCR), the BCR mostly expressed on memory B cells, contains a distinct signaling
function from IgM-BCR or IgD-BCR expressed on naı ¨ve B cells. Because naı ¨ve B cells transgenic for IgG exhibit augmented
response to antigens similar to memory B cells, the distinct signaling function of IgG-BCR appears to play a role in
augmented antibody responses of memory B cells. However, how IgG-BCR signaling augments B cell responses is not yet
well understood. Here we demonstrate that B cells from IgG-transgenic mice are anergic with defect in generation of BCR
signaling upon BCR ligation. However, these IgG-transgenic B cells generate markedly augmented antibody response to a T
cell-dependent antigen, probably due to hyper-responsiveness to a T cell-derived signal through CD40. Both BCR signaling
defect and augmented response to CD40 ligation are partially restored in xid IgG-transgenic mice in which BCR signaling is
down-modulated due to a loss-of-function mutation in the tyrosine kinase Btk crucial for BCR signaling. Thus, IgG-BCR
induces augmented B cell responses in the absence of antigen-induced BCR signaling probably through high ligand-
independent BCR signaling that may ‘‘idle’’ B cells to make them ready to respond to T cell help. This finding strongly
suggests a crucial role of ligand-independent signaling in receptor function.
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Introduction
The B cell antigen receptor (BCR), composed of the membrane
form of immunoglobulin and Iga/Igb, plays a crucial role in both
development and homeostasis of B cells as well as their responses to
antigen stimulation [1]. BCR signaling generated in the absence of
antigen, its ligand, is known as tonic BCR signaling, and is essential
for maintenance of B cell population by inducing survival of B cells
[2,3]. Moreover, signal strength of the tonic BCR signaling appears
to regulate whether immature B cells differentiate to either one of
the two major subsets of conventional B cells, i.e., follicular B cells
and marginal zone B cells [1,4]. B cells deficient in BCR signal
components such as Btk favor marginal zone B cell fate whereas
those deficient in negative regulators of BCR such as CD22 favor
follicular B cell fate, suggesting that differentiation to follicular B
cells requires high tonic BCR signal strength, whereas low tonic
BCR signaling induces differentiation to MZ B cells. In contrast, the
number of MZ B cells is increased in some autoantibody-transgenic
mouse lines carrying mostly self-reactive B cells [5–7], suggesting
that continuous BCR ligation by interaction with self-antigens may
also induces differentiation to MZ B cells.
Continuous BCR signaling generated by interaction with self-
antigens during B cell development causes B cell anergy, in which
B cells are no longer activated for proliferation and differentiation
to plasma cells after antigen stimulation [8]. Silencing self-reactive
B cells by inducing anergy may play a role in maintenance of
self-tolerance. Anergic B cells characteristically exhibit reduced
BCR expression on the surface [8,9] and augmented expression of
molecules such as CD44 [8,10], Fas [11,12] and CD93 [13].
Recently, Merrel et al. [13] demonstrated that anergic B cells
are accumulated in B220
+CD93
+IgM
loCD23
+ T3 B cells. Ex
vivo analysis of anergic B cells has demonstrated that baseline
activation of BCR signaling molecules is augmented whereas BCR
ligation generates only a weak signaling [8,14], suggesting that
ligation-induced BCR signaling is perturbed probably due to
continuous BCR signaling in vivo.
Among the five distinct classes of immunoglobulins, IgG-
containing BCR (IgG-BCR), the BCR mostly expressed on
memory B cells, exhibits a distinct signaling function from IgM-
BCR or IgD-BCR [15–17], both of which are expressed on naı ¨ve
B cells. Transgenic B cells expressing IgG or chimeric IgM/G
containing the extracellular region of IgM and cytoplasmic tail of
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8815IgG exhibit augmented antibody production after primary antigen
stimulation [16]. This finding indicates that expression of IgG
instead of IgM or IgD augments antibody response in naı ¨ve B cells
probably by augmented signaling through IgG-BCR, and that the
cytoplasmic tail of IgG plays a role in augmented BCR signaling.
As memory B cells mostly express IgG-BCR, augmented antibody
production during memory responses may involve augmented
signaling function of IgG-BCR. In B cell lines, ligation of IgG-
BCR induces stronger signaling including Ca
2+ mobilization and
phosphorylation of ERK than ligation of IgM or IgD does [15,18].
Recent studies have demonstrated that increased Ca
2+ mobiliza-
tion is also induced by BCR ligation in transgenic B cells
expressing IgG or IgM/G [17,19]. In these transgenic B cells,
however, both phosphorylation of signaling molecules such as
ERK and expression of BCR-induced genes induced by BCR
ligation are rather diminished compared to IgM-expressing B cells.
Thus, the model in which augmented signaling induced by IgG-
BCR ligation causes augmented antibody production is no longer
valid.
In this study, we established mice transgenic for IgG reactive to
the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP) to address how
IgG-BCR induces augmented antibody responses. Although the
number of B cells is markedly reduced, antibody production
of IgG-transgenic (IgG-tg) B cells was markedly augmented
after immunization with a T cell-dependent protein antigen, in
agreement with previous observations [16,20–22]. Surprisingly,
these B cells did not generate signaling after BCR ligation in vitro,
but showed augmented proliferation upon ligation of CD40, the
receptor of the T cell-derived co-stimulatory signal CD40L
(CD154). IgG-tg B cells exhibited increased basal signaling,
suggesting the presence of high tonic signaling through IgG-
BCR, and defects in B cell generation and BCR signaling were
partially restored in IgG-tg mice carrying the loss-of-function xid
mutation in the BCR signaling molecule Btk probably through
reduction of tonic BCR signaling. These results suggest that high
tonic BCR signaling causes both decrease in the B cell number and
BCR signaling defect. Moreover, high tonic IgG-BCR signaling
may cause hyper-proliferation upon CD40 ligation as CD40
signaling synergistically induces B cell proliferation with BCR
signaling. Thus, IgG-BCR generates high tonic signaling thereby
generating augmented antibody responses to T cell-dependent
antigens in the absence of antigen-induced BCR signaling
probably by augmented proliferative responses to the T cell-
derived signal CD40L.
Results
B Cells Expressing IgG-BCR Exhibit an Anergic Phenotype
To address the functional properties of IgG-BCR, we generated
transgenic mice expressing anti-NP Ig c2a chain (Figure 1a), and
crossed these mice with Ig k chain-deficient mice, resulting in IgG-
tg mice in which almost all the B cells express NP-reactive IgG2a
because of its expression of both VH186.2-containing anti-NP Ig
c2a chain and l L chain [23,24]. We established two independent
Ig c2a chain-transgenic mouse lines, and used one of them for this
study, but the other line shows basically the same phenotype. As a
control, we generated anti-NP IgM-tg mice that express both
VH186.2-containing Ig m chain (Figure 1b) and l L chain in
almost all the B cells. First, we analyzed B cell development in the
bone marrow and spleen of IgM-tg and IgG-tg mice by flow
cytometry. In IgG-tg bone marrow, the percentage of
B220
+CD43
+ pro B cells was markedly increased whereas that
of B220
+CD43
2 pre B cells was decreased (Figure 2a), suggesting
that maturation of pro B to pre B cells is perturbed. The
percentage of B220
+ B cells in the spleen was markedly reduced
(Figure 2b), probably due to poor B cell production in the bone
marrow. Analysis of spleen B cells demonstrated both increase in
the percentage of B220
+CD21
hiCD23
lo/2 marginal zone (MZ) B
cells and decrease in B220
+CD21
interCD23
+ follicular B cells.
Thus, expression of IgG induced severe maturational block from
pro B to pre B cells, and biased differentiation to MZ B cells over
follicular B cells.
When we analyzed phenotype of spleen B cells, binding to the
antigen NIP was 10 times lower in IgG-tg B cells than that in IgM-
tg B cells, indicating that BCR expression is down-modulated in
IgG-tg B cells (Figure 2c). IgG-tg B cells exhibited increased
expression of CD44 and decreased expression of CD23, whereas
expression of other molecules including CD19, CD22, CD40,
CD86, CD93, CD95 and MHC class II was not altered compared
to IgM-tg B cells (Figure 2d). Because reduced expression of BCR
and CD23, and increased expression of CD44 were shown in
anergic B cells, these results indicated that IgG-tg B cells show
anergic phenotype.
IgG-tg B Cells Do Not Respond to BCR Ligation but
Generate Augmented Response to Co-Stimulation
To ask the signaling function of IgG-BCR, we purified CD23
+
follicular B cells from IgM-tg and IgG-tg spleen (Figure 3a), and
stimulated with the antigen NP-BSA. After antigen stimulation,
various cellular substrates including ERK were tyrosine-phos-
phorylated, and both intracellular Ca
2+ concentration and CD86
expression were increased in IgM-tg B cells (Figure 3b–d). The
basal level of substrate phosphorylation and intracellular Ca
2+
concentration in unstimulated IgG-tg B cells were higher than that
in IgM-tg B cells (Figure 3b–c), indicating high tonic signaling
through IgG-BCR. However, antigen stimulation did not increase
either substrate phosphorylation, intracellular Ca
2+ concentration
or CD86 expression in IgG-tg B cells (Figure 3b–d), indicating that
BCR ligation does not generate signaling in these B cells. As
continuous BCR signaling generated by interaction with self-
antigen causes B cell anergy including signal defect upon ex vivo
BCR ligation [8,14], high tonic signaling through IgG-BCR may
be involved in BCR signal defect in IgG-tg B cells.
B cells undergo proliferation when BCR is ligated by anti-Ig
antibodies. In contrast, BCR ligation by antigen induces apoptosis,
and BCR-ligated B cells require co-stimulatory signaling through
Figure 1. Schematic representation of Ig c2a and m H chain
constructs. Wide boxes indicate protein coding regions, and filled
circle represents the m intron enhancer(EH). E, EcoRI; K, KpnI; X, XhoI.
IgG-Transgenic B Lymphocytes
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8815Figure 2. Flow cytometry analysis of bone marrow and spleen cells from wild type (WT) C57BL/6, IgM-tg and IgG-tg mice. (A) Analysis
of bone marrow cells. Cells were stained for B220, IgM, and CD43. Percentages of pro B cells (IgM
2, B220
+, CD43
+), pre B cells (IgM
2, B220
+, CD43
2),
immature B cells (B220
lo, IgM
med), transitional B cells (B220
+, IgM
hi), and mature B cells (B220
hi, IgM
med) are calculated. Numbers of mice analyzed are
indicated, and data are shown as mean (6SD) (bottom). (B) Subsets of spleen B cells. Spleen cells were stained for CD3, B220, CD21 and CD23.
Percentages of T cells and B cells (left panel) in total spleen cells, and those of MZ B cells (B220
+, CD21
hi, CD23
lo/2) and follicular B cells (B220
+,
CD21
inter, CD23
hi) in total B cells (right panel) are calculated. Numbers of mice analyzed are indicated, and data are shown as mean (6SD) (bottom).
(C) Expression of BCR on spleen B cells. Spleen cells were stained for NIP binding, IgG2a, IgM and B220. Mean fluorescence intensity (MFI) of NIP
binding is indicated. (D) Expression of various molecules on spleen B cells. Spleen cells from IgG-tg (open histograms) and IgM-tg (shaded
histograms) mice were analyzed for expression of CD40, CD22, CD19, MHC class II, CD86, CD44, CD23, Fas, and CD93. All histograms are gated on
B220
+ cells.
doi:10.1371/journal.pone.0008815.g002
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8815Figure 3. IgG-tg B cells generate an augmented proliferative response to CD40 ligation but no antigen-induced BCR signaling.
CD23
+ follicular B cells were isolated from IgM-tg and IgG-tg spleen by magnet sorting. (A) Purity of CD23
+ follicular B cells used for in vitro analysis.
Expression of B220 and CD23 was analyzed by flow cytometry. Percentages of B220
+CD23
+ follicular B cells are indicated. (B and C) Antigen-induced
BCR signaling. Purified CD23
+ follicular B cells were stimulated with 0.2 mg/ml NP15-BSA for 2 and 5 min. Phosphorylation of cellular substrates in total
cell lysates (B, upper panel) and that of ERK (B, middle panel) were analyzed by Western blotting. Western blot analysis of b-tubulin was done as a
loading control (B, lower panel). Alternatively, cells were loaded with Fluo-4/AM, and intracellular free Ca
2+ was measured by flow cytometry (C). Cells
were added with 0.2 mg/ml NP15-BSA at 25s as indicated by arrows, and measurement of free Ca
2+ was continued for 200s. Representative data of
three experiments are shown. (D) Expression of CD86. Purified CD23
+ follicular B cells were cultured with or without 0.2 mg/ml NP15-BSA for 48 hrs,
and analyzed for expression of CD86 by flow cytometry. Percentage of CD86
+ cells is indicated. (E) Apoptosis of B cells. Purified CD23
+ follicular B cells
were cultured with indicated reagents for 24 hrs. Percentages of apoptotic cells with hypodiploid DNA were measured by flow cytometry. Data are
shown as average of three experiments (6SD). (F) Cell cycle progression of B cells. Purified CD23
+ follicular B cells were cultured with indicated
reagents for 48 hrs, and were pulsed with BrdU for the last 20 min of the culture. Percentages of BrdU-incorporated cells (% S phase) were measured
by flow cytometry. Data are shown as average of three experiments (6SD). (G) Division of B cells. Purified CD23
+ follicular B cells were labeled with
CFSE, and cultured with anti-CD40 antibody for 72 hrs. Cells were analyzed by flow cytometry for CFSE labeling. The numbers of cell division are
indicated.
doi:10.1371/journal.pone.0008815.g003
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cell response to BCR ligation and co-stimulation, we cultured
purified follicular B cells with various stimuli including antigen,
anti-Ig antibodies and anti-CD40 antibody. Both anti-IgM and
anti-l antibodies reduced apoptosis and induced cell cycle
progression to the S phase in IgM-tg B cells (Figure 3e–g),
although anti-IgM antibody induced survival and cell cycle
progression more efficiently than anti-l antibody did. In contrast,
anti-IgG antibody or anti-l antibody did not induce survival or
cell cycle progression in IgG-tg B cells, supporting the notion that
BCR ligation does not generate signaling in IgG-tg B cells.
However, when we stimulated B cells with anti-CD40 Ab, IgG-tg
B cells progressed into the cell cycle more efficiently than IgM-tg B
cells did (Figure 3e–g). Both reduced proliferative response to BCR
ligation and augmented response to CD40 ligation exhibited by
IgG-tg follicular B cells are shared by MZB cells from normal mice
[26–28]. However, these functional properties of MZB cells may
not contribute to the altered response of IgG-tg B cells as we used
highly purified follicular B cells for this study (Figure 3a). This
notion is further supported by our finding that IgG-tg B cells do
not generate signaling upon BCR ligation whereas MZB cells
exhibit rather augmented BCR ligation-induced signaling [26,29].
As CD40 signaling activates B cells synergistically with BCR
signaling, IgG-tg follicular B cells efficiently undergo cell cycling
by stimulation with anti-CD40 antibody probably due to
augmented tonic BCR signaling.
Augmented Antibody Production in IgG-tg Mice
To address Ab production in IgM-tg and IgG-tg mice, we first
measured serum levels of Ig transgene-derived Ab in untreated
mice. The serum concentration of anti-NP Ab in IgG-tg was
almost 100 times higher than that in IgM-tg mice (Figure 4a).
When we histologically analyzed spleen sections, a large number of
IgG
+ plasma cells were accumulated in the red pulp in
unimmunized IgG-tg mice (Figure 4b). This result indicated that
B cells undergo spontaneous maturation to plasma cells in these
mice.
Next, we addressed in vivo Ab responses to antigen stimulation.
To avoid blocking of antigen by secreted antibodies in IgM and
IgG-tg mice, we purified follicular B cells from IgM-tg and IgG-tg
spleen, and transferred them to the Ly5.1
+ recipient mice that do
not spontaneously produce anti-NP antibody. Because donor B
cells express Ly5.2 and carry the transgene encoding IgM
a or
IgG2a
a, donor-derived B cells and Ab can be distinguished from
those of recipient mice (Ly5.1
+, IgM
b, IgG2a
b). When the recipient
mice were immunized with the T cell-dependent protein antigen
NP-CGG, both the number of donor-derived B cells and AFCs
generated from donor B cells were increased regardless whether
donor B cells were obtained from IgM-tg or IgG-tg mice
(Figure 5a–b). IgG-tg B cells generated a much larger number of
AFCs than IgM-tg B cells did especially at the early phase of the
response, indicating that IgG-tg B cells rapidly mature to plasma
cells. In contrast, the increase in the number of IgG-tg B cells was
not so extensive as that of IgM-tg B cells after immunization.
However, when we transferred CFSE-labeled donor B cells, IgG-
tg B cells exhibited more dilution of CFSE than IgM-tg B cells did
(Figure 5c), indicating rapid division of IgG-tg B cells compared to
IgM-tg B cells. These results suggested that, after immunization,
IgG-tg B cells expand more rapidly than IgM-tg B cells but mature
to plasma cells more efficiently, resulting in mild reduction in the
number of IgG-tg B cells. Moreover, IgG-tg B cells differentiated
to B220
+CD38
lo GC B cells more rapidly than IgM-tg B cells
(Figure 5d). Taken together, IgG-tg B cells rapidly expand,
and differentiate to both GC B cells and plasma cells after
immunization with T cell-dependent antigens.
IgG-tg B Cells Do Not Respond to In Vivo Stimulation
with a T Cell-Independent Polysaccharide Antigen
Polysaccharide antigens such as dextran and Ficoll induce T
cell-independent antibody production probably because BCR is
extensively ligated by highly repetitive structure of these antigens
[30]. To address the response of IgG-tg B cells that depends on
BCR signaling alone, we transferred IgM-tg and IgG-tg B cells to
recipient mice, and immunized them with the T cell-independent
antigen NP-Ficoll. After immunization, IgM-tg B cells underwent
cell division, expanded and differentiated to AFCs (Figure 6a–c).
However, IgG-tg B cells did not show cell division, expansion or
differentiation to AFCs at all. Thus, IgG-tg B cells do not respond
Figure 4. Augmented antibody production in unimmunized
IgG-tg mice. (A). Serum levels of anti-NP IgM, IgG2a, and l L chain-
containing Ig. Sera from 13-wk-old IgM-tg and IgG-tg mice were
analyzed by ELISA. Data are shown as mean 6 SD. (B). Histological
analysis. Frozen spleen sections from upper IgM-tg (left panel), IgG-tg
(right upper panel) and wild type (WT) C57BL/6 (lower panes) mice were
stained either anti-IgM
a Ab (left upper panel), anti-IgG2a Ab (right
upper panel) (red), anti-IgM Ab (left lower panel) or anti-IgG2a (right
lower panel) together with anti-CD38 Ab (green).
doi:10.1371/journal.pone.0008815.g004
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PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8815Figure 5. IgG-tg B cells rapidly differentiate to AFCs and GC B cells after immunization with a T cell-dependent antigen. Splenic
CD23
+ follicular B cells were isolated from IgM-tg and IgG-tg mice by magnet sorting as indicated in the legend of Figure 2. Either untreated (A, B and
D) or CFSE-labeled (C) follicular B cells (4610
5) were injected intravenously into CGG-primed B6.Ly5.1 mice. One day later, recipients were immunized
intraperitoneally with 50 mgN P 25-CGG in alum. Indicated days after immunization, spleen cells from recipient mice were obtained. (A) Expansion of
donor-derived B cells. Cells were stained for B220 and Ly5.2, and analyzed by flow cytometry. Dead cells were excluded by staining with DAPI.
Representative flow cytometry plots are shown (upper panel). Numbers of donor-derived B cells (B220
+, Ly5.2
+)i n1 610
6 total spleen cells were
calculated (lower panel). Circles represent data from individual recipients, and bars show the mean of each group. Closed circles and solid line,
recipients transferred with IgG-tg B cells; Open circles and dotted line, recipients transferred with IgM-tg B cells. Statistical analysis was done by
Student’s t-test (*, p,0.05; **, p,0.01; ***, p,0.001). (B) Generation of donor-derived AFCs. Frequency of AFCs secreting donor-derived Abs in 1610
6
total spleen cells from recipients that received IgM-tg B cells or IgG-tg B cells were measured by an ELISPOT assay. Circles and lines are as in the
legend to Figure 4A. Statistical analysis was done by Student’s t-test (*, p,0.05; **, p,0.01; ***, p,0.001). (C) Division of donor-derived B cells in
recipients. Dilution of CFSE in Ly5.2
+ donor-derived cells was analyzed by flow cytometry. The numbers of the cell division are indicated. As a negative
control, recipients were i.p. injected with PBS instead of NP-CGG/Alum, and analyzed in parallel (open histogram). Percentages of cells that
underwent cell division are indicated. Data are representative of two independent experiments. (D) Generation of donor-derived GC B cells. Cells
were stained for B220, CD38 and Ly5.2, and analyzed by flow cytometry. Dead cells were excluded by staining with DAPI. Percentages of donor-
derived GC B cells (B220
+, Ly5.2
+, CD38
lo)i n2 610
5 total spleen cells are indicated. Representative data of three experiments are shown.
doi:10.1371/journal.pone.0008815.g005
IgG-Transgenic B Lymphocytes
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Ficoll probably due to BCR signaling defect.
The Xid Mutation of Btk Partially Restores B cell
Abnormalities in IgG-tg Mice
To reduce tonic BCR signaling, we crossed IgG-tg mice with
xid mice carrying a loss-of-function mutation in the tyrosine kinase
Btk crucial for BCR signaling [31,32]. In xid IgG-tg mice, the
number of B cells was markedly increased although the level of
BCR expression was not altered (Figure 7a). In contrast, the
number of MZ B cells was reduced (Figure 7b), although xid non-
transgenic mice show rather increased generation of MZ B
cells [33–35]. Xid IgG-tg B cells exhibited reduced proliferative
response to anti-CD40 antibody (Figure 7c), and BCR ligation-
induced tyrosine phosphorylation of cellular substrates was
partially restored (Figure 7d). Thus inhibition of tonic BCR
signaling by introduction of the xid mutation partially restores
abnormalities in IgG-tg mice such as reduced B cell production,
increased generation of MZ B cells, augmented B cell response to
CD40 ligation and BCR signaling defect. These results suggest
that augmented tonic signaling through IgG-BCR plays a role in B
cell abnormalities in IgG-tg B cells.
Discussion
Here we demonstrate that IgG-tg B cells expressing NP-reactive
IgG exhibit reduced BCR expression on the cell surface and BCR
signaling defect, both of which are characteristically shown in
anergic self-reactive B cells [9,11,36,37]. Other phenotypes found
in IgG-tg B cells such as increased number of MZ B cells
[16,17,38], reduced CD23 expression [10] and increased CD44
expression [8,10] are also found in anergic self-reactive B cells. In
contrast, IgM-tg B cells expressing IgM carrying the same antigen
specificity as in IgG-tg B cells do not exhibit anergic phenotypes,
suggesting that antigen specificity of IgG-tg B cells are not
responsible for the anergic phenotypes. Although IgG-tg B cells
express endogenous IgM, the anergic phenotype is caused by
expression of IgG as IgM expression does not induce such a
phenotype. Because anergy is caused by continuous BCR signaling
induced by interaction with self-antigens [12], anergy-like
phenotypes of IgG-tg B cells suggest continuous signaling through
Figure 6. IgG-tg B cells do not respond to a T cell-independent polysaccharide antigen. Splenic CD23
+ follicular B cells were isolated from
IgM-tg mice and IgG-tg mice by magnet sorting as indicated in the legend to Figure 2. Follicular B cells (4610
5) were injected intravenously into
B6.Ly5.1 mice. One day later, recipients were immunized intravenously with 50 mgN P 50-Ficoll in PBS. Expansion of donor-derived B cells (A),
generation of donor-derived AFCs (B), and cell division of donor-derived B cells in recipients (C) were analyzed as in the legend to Figure 5.
doi:10.1371/journal.pone.0008815.g006
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antigens. It is already well established that continuous low-level
BCR signaling known as tonic BCR signaling is generated in
normal B cells in the absence of antigen, and plays a crucial role in
maintenance of B cell homeostasis [2,3]. In IgG-tg B cells, efficient
signaling capacity of IgG-BCR [15,18] may cause tonic BCR
signaling as strong as BCR signaling generated by antigen
stimulation in self-reactive B cells. High tonic BCR signaling in
IgG-tg B cells is supported by increased basal activation of
signaling molecules compared to IgM-tg B cells, and also accounts
for the induction of augmented proliferative response of IgG-tg B
cells induced by CD40 ligation. CD40 signaling induces pro-
liferation of B cells synergistically with antigen stimulation. High
tonic signaling through IgG-BCR appears to substitute for
antigen-induced BCR signaling, and thus CD40 ligation alone
may induce efficient proliferation of IgG-tg B cells. Moreover,
down-modulation of tonic BCR signaling by introducing the xid
mutation of Btk partially restores B cell abnormalities in IgG-tg
mice including reduction of B cells, skewed maturation to marginal
zone B cells, augmented proliferative response to CD40 ligation
Figure 7. The Xid mutation of Btk partially restores abnormalities of IgG-tg B cells. (A) BCR expression of B cells. Spleen cells from
indicated mice were stained for NIP binding, IgG2a, IgM and B220, and analyzed by flow cytometry. Percentages of B cells are indicated. (B) Subsets of
spleen B cells. Spleen cells were stained for B220, CD21 and CD23. Percentages of MZ B cells (B220
+, CD21
hi, CD23
lo/2) and follicular B cells (B220
+,
CD21
inter, CD23
hi) are indicated. (C) Proliferation of B cells. Purified CD23
+ follicular B cells were labeled with CFSE, and cultured with anti-CD40
antibody for 72 hrs. Cells were analyzed by flow cytometry for CFSE labeling. The numbers of cell division are indicated. (D) BCR ligation-induced
tyrosine phosphorylation of cellular substrates. Purified CD23
+ follicular B cells were stimulated with 0.2 mg/ml NP15-BSA for 2 and 5 min.
Phosphorylation of cellular substrates in total cell lysates (upper panel) was analyzed by Western blotting. Western blot analysis of b-tubulin was
done as a loading control (lower panel).
doi:10.1371/journal.pone.0008815.g007
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tonic BCR signaling is responsible for these phenotypes of IgG-tg
B cells. Taken together, high tonic BCR signaling appears to
induce anergy-like phenotypes but efficient CD40-mediated B cell
expansion in IgG-tg B cells.
We demonstrate here that IgG-tg B cells exhibit augmented in
vivo response to a protein antigen, in agreement with the previous
finding by Martin et al. [16]. Antigen stimulation induces rapid
expansion of IgG-tg B cells and their differentiation to plasma
cells. However, the antigen stimulation does not generate BCR
signaling, indicating that IgG-tg B cells respond to antigen without
generating BCR signaling. After antigen stimulation, the antigenic
peptide presented by B cells is recognized by specific T helper
cells, resulting in antigen-specific interaction of B cells with T
helper cells [39,40]. This interaction may efficiently activate IgG-
tg B cells because T cell-derived CD40 signaling alone induces
efficient proliferation of these B cells probably due to high tonic
BCR signaling. By this mechanism, IgG-tg B cells may produce
specific antibodies without generating BCR signaling.
Ligand-induced activation of signaling molecules is generally
thought to define the signaling function of receptors. However, our
findings on BCR in this study suggest that ligand-independent
basal signaling, or tonic signaling, plays a crucial role in signaling
function thereby regulating cell activation. As a consequence,
ligand-dependent signaling may not necessarily represent receptor
function. The role of tonic signaling in the function of receptors
other than BCR should be elucidated in the future.
‘‘Idling’’ Model for B Lymphocyte Activation
Studies on signaling function on IgG-BCR in primary B cells
including our present study have demonstrated that IgG-BCR
transmits a distinct signaling although the signaling properties of
IgG-BCR in primary B cells are still controversial [17,19]. Knock-
in B cells in which the C region of IgM is replaced by that of IgG
or those in which the cytoplasmic tail of IgM is replaced by
that of IgG exhibit augmented Ca
2+ signaling upon BCR ligation.
In contrast, both MAPK activation and BCR-mediated gene
expression were reduced in these knock-in B cells. What causes the
discrepancy between Ca
2+ signaling and other signaling pathways
including MAPK activation is not yet known. However, depressed
BCR ligation-induced signaling may be due to augmented tonic
signaling through IgG-BCR. As BCR ligation-induced signaling is
not completely abrogated in these knock-in mice, tonic signaling in
these knock-in B cells may not be so high as in IgG-tg B cells in our
study, and mildly increased tonic signaling may allow these knock-
in B cells to generate BCR signaling to some extent. The Ig V
genes are fixed in our IgG-tg B cells, whereas variety of V genes
can be used in these knock-in B cells. In IgG knock-in B cells, VH
genes that generate less tonic signaling may be selected. This
assumption is supported by the finding that surface IgG expression
is only mildly down-modulated in these knock-in mice [17,19]
compared to IgG-transgenic mice including our expressing VH-
fixed IgG [23,41,42].
Although very high tonic BCR signaling may cause BCR signal
defect upon BCR ligation, studies on CD22-deficient B cells
suggest that such high tonic BCR signaling may not necessarily be
required for augmented response to co-stimulation. B cells
deficient in CD22, a negative regulator of BCR signaling, appear
to generate increased tonic BCR signaling because of reduced
surface BCR expression [43–46]. In these B cells, BCR ligation-
induced signaling is rather augmented, suggesting that tonic
signaling is not high enough to down-regulate ligation-induced
BCR signaling. However, CD22-deficient B cells are hyper-
responsive to CD40 ligation [47,48], and generate augmented Ab
response [49]. Thus, mildly increased tonic signaling may augment
reactivity to T cell help in both CD22-deficient B cells and IgG tail
knock-in B cells. Horikawa et al. [17] proposed ‘‘less-is-more’’
hypothesis in which less BCR-mediated gene expression is
involved in augmented response of IgG
+ B cells. Here we propose
an alternative ‘‘idling’’ model in which high tonic signaling induces
augmented B cell response by ‘‘idling’’ B cells so that they become
ready to respond to co-stimulation.
The present study suggests that tonic BCR signaling regulates B
cell response to antigen and T cell help. High tonic IgG-BCR
signaling may be involved in augmented Ab production from IgG
+
memory B cells, although BCR signaling properties of memory B
cells is not yet well understood. High tonic IgG-BCR signaling
may reflect strong BCR signaling capacity of IgG-BCR. However,
molecular basis for efficient BCR signaling through IgG-BCR is
not yet known. Previously, we stimulated various B cell lines with
antigens, and demonstrated that IgG-BCR signaling is only weakly
regulated by CD22 compared to IgM-BCR signaling [15]. In
contrast, recent studies using IgG knock-in mice showed that
CD22 regulates IgG-BCR signaling as well as IgM-BCR signaling
generated by treatment with anti-Ig Ab. This discrepancy may be
caused by difference in cells, reagents for BCR ligation or both
[15,17,18,19]. B cell lines appear to be resistant to tonic signaling-
induced BCR signal regulation, and antigens induce stronger
CD22-mediated signal regulation than anti-Ig Abs [25]. Recently,
Engels et al. [50] demonstrated using B cell lines that tyrosine
residue at the cytoplasmic tail of the membrane form of IgG is
phosphorylated upon BCR ligation, and recruits Grb2 thereby
augmenting BCR signaling. Multiple mechanisms may be
involved in strong signaling capacity of IgG-BCR, and further
studies are required to elucidate the molecular mechanisms for
determining the level of tonic BCR signaling.
Materials and Methods
Ethics Statement
All experiments were approved by the animal committee of
Tokyo Medical and Dental University.
Mice
The transgene construct pIgG2a-NP encoding anti-NP Ig c2a
chain was generated by inserting a 4kb EcoRI fragment of
pSVneoG2am (a kind gift of Dr. Reth) containing the rearranged
VH186.2 gene segment into EcoRI-digested p1121 containing the
Cc2a gene [23] (a kind gift of Dr. Eibel). A 21-kb PvuI-KpnI
fragment of pIgG2a-NP and a 12-kb PvuI-XhoI fragment of pSV-
Vm1 [51] that encodes anti-NP Ig m chain were injected into
fertilized C57BL/6 eggs. The transgenic mice expressing anti-NP
Ig m and c2a chains were crossed with Ig k chain-deficient mice
[24], resulting in IgM-tg and IgG-tg mice. The amino acid
sequence of the cytoplasmic tail of Ig m chain and that of Ig
c2a chain are KVK and KVKWIFSSVVELKQTISPDYRN-
MIGQGA, respectively [52]. Xid mice (a gift of Dr. Takatsu) are
described previously [31,32]. All the mice were maintained in our
animal facility under SPF conditions.
Adoptive Transfer and Immunization
Spleen cells were prepared from either IgM-tg or IgG-tg mice,
and erythrocytes were lysed by incubation with a solution
consisting of 0.15 M NH4Cl, 10 mM KHCO3 and 0.1 mM
EDTA, pH7.2. Cells were stained with PE-conjugated anti-CD23
Ab (BD Pharmingen) followed by incubation with anti-PE
microbeads (Miltenyi Biotec), and CD23
+ follicular B cells were
purified using an autoMACS (Miltenyi Biotec). The purity of
IgG-Transgenic B Lymphocytes
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+ cells was determined by flow cytometry using a LSR
(Becton Dickinson) (purity .95%). In some experiments, cells
were labeled with 5 mM CFSE (Molecular Probes) as described
previously [53]. For analyzing the T cell-dependent response, Ly5-
congenic C57BL/6 (B6.Ly5.1) [54] mice were treated intraperi-
toneally with 100 mg chicken c-globulin (CGG) in CFA. After 7
days, mice were injected intravenously with 4610
5 purified CD23
+
cells. One day later, recipients were immunized intraperitoneally
with 50 mgN P 25-CGG in alum. For analyzing the T cell-
independent response, Ly5-congenic C57BL/6 (B6.Ly5.1) mice
were injected intravenously with 4610
5 purified CD23
+ cells. One
day later, recipients were immunized intravenously with 50 mg4 -
hydroxy-3-nitrophenyl acetyl (NP)- conjugated Ficoll (NP50-Ficoll)
in PBS.
ELISA and ELISPOT
Serum anti-NP Ab titers were measured by an ELISA using 96-
well plates coated with NP-BSA and anti-mouse Ig Ab specific to
Ig M, IgG2a or l L chain (Southern Biotechnology Associates).
Splenic Ab-forming cells (AFCs) were measured by standard
ELISPOT assay as described previously [55]. In brief, Multi-
Screen-HA 96-well plates (Millipore) were coated with 50 mg/ml
anti-l Ab (Southern Biotechnologies). Spleen cells were distributed
to the plates and were incubated for 5 h at 37uCi naC O 2
incubator. Plates were incubated with biotin-labeled anti-IgM
a Ab
and anti-IgG2a
a Ab followed by reaction with alkaline phospha-
tase-labeled streptavidin (BD PharMingen).
Flow Cytometry
Spleen cells were incubated with anti-low-affinity Fc receptor
for IgG (FccRII/III) Ab (2.4G2), and were stained with the
following reagents: biotin-labeled anti-CD43 Ab, FITC-labeled
anti-IgM Ab (Southern Biotechnologies), FITC- and Alexa
Fluor 647-labeled anti-B220 Ab, FITC-labeled anti-CD3 Ab
(eBioscience), PE-labeled anti-CD23 Ab (eBioscience), FITC-
labeled anti-CD21 Ab (eBioscience), biotin-labeled anti-IgG2a
Ab (Southern Biotechnologies), biotin-labeled anti-CD40 Ab (BD
PharMingen), FITC-labeled anti-CD22 Ab, biotin-labeled anti-
CD19 Ab (BD PharMingen), biotin-labeled anti-MHC class II Ab
(BD PharMingen), PE-conjugated anti-CD86 Ab (BD PharMin-
gen), Alexa Fluor 647-labeled anti-Fas Ab, biotin-labeled anti-
CD93 Ab (BD PharMingen), PE-conjugated anti-mouse/human
CD44 (eBioscience), FITC- and biotin-labeled anti-Ly5.2 Ab, PE-
conjugated anti-CD38 Ab (BD PharMingen), 4-hydroxy-3-iodo-5-
nitrophenyl acetyl-conjugated phycoerythrin (NIP-PE), Biotin-
labeled Abs were visualized by PerCP-conjugated streptavidin (BD
PharMingen). 4, 6-diamino-2-phenylindole (DAPI) (SIGMA) was
used for exclusion of dead cells. Cells were analyzed using a LSR
with CELLQuest
TM software (Becton Dickinson).
Immunohistochemical Analysis
Spleens were embedded in Tissue-Tek O.C.T. compound
(Sakura, The Netherlands), snap-frozen in liquid nitrogen and
stored at 280uC. Cryostat sections (7-mm thick) were mounted
onto slide glass, air dried, and fixed in acetone for 20 min at room
temperature. The sections were incubated with blocking buffer
(PBS containing 0.5% BSA and 0.05% NaN3) containing anti-
FccRII/III Ab (2.4G2) for 30 min, and were stained at room
temperature for 60 min with PE-conjugated anti-CD38 Ab, and
either biotin-labeled anti-IgM
a Ab/anti-IgM or biotin-labeled
anti-IgG2a Ab, followed by reaction with FITC-labeled strepta-
vidin (DAKO). The sections were analyzed with a confocal laser-
scanning microscope LSM510 (Carl Zeiss).
Cell Culture
Cells were labeled with 2 mM CFSE (Molecular Probes) as
described previously [49,54]. CFSE-labeled or unlabeled cells
were cultured in RPMI 1640 medium supplemented with 10%
FCS, 50 mM 2-ME, and 1mM glutamine. Purified CD23
+
follicular B cells (1,2610
5) were cultured in 200 ml of the culture
medium with 0.2 mg/ml of the antigen NP15-BSA, 10 mg/ml anti-
CD40 mAb FGK45 or both. Alternatively, cells were cultured
with 10 mg/ml anti-IgM F(ab9)2, anti-IgG(H+L) F(ab9)2 or anti-l L
chain Ab. Cells were collected, and the percentages of apoptotic
cells were estimated by flow cytometric measurement of cells with
hypodiploid DNA. For assessing cell cycling, cells were pulsed
with 20 mM 5-bromo-29-deoxyuridine (BrdU) for the last 20 min
of culture, and then fixed with 70% ethanol overnight at 220uC.
Cells were stained with FITC-labeled anti-BrdU Ab (BD
PharMingen) and propidium iodide, and analyzed by flow
cytometry using a FACSCalibur (BD PharMingen). CFSE-labeled
cells were analyzed by flow cytometry for CFSE fluorescence.
Western Blotting
Purified CD23
+ follicular splenic B cells were stimulated with
0.2 mg/ml NP15-coupled BSA (NP-BSA). Cells were lysed in
Trinton X-100 lysis buffer (1% Triton X-100, 10% glycerol,
150 mM NaCl, 2 mM EDTA, 0.02% NaN3,1 0mg/ml PMSF,
and 1 mM Na3VO4). Total cell lysates were separated on SDS-
PAGE and transferred to polyvinylidene difluoride membranes.
Membranes were incubated with peroxidase-conjugated anti-
phosphotyrosine mAb 4G10 (Upstate Biotechnology). Alternative-
ly, membranes were reacted with rabbit anti-mouse phospho-ERK
Ab (New England Biolabs), or followed by peroxidase-conjugated
anti-rabbit IgG Ab (New England Biolabs), or anti-b-tubulin mAb
TUB 2.1 (Seikagaku Kogyo) followed by reaction with peroxidase-
conjugated anti-mouse IgG Ab (Amersham Biosciences). Proteins
were then visualized with an ECL system (Amersham Biosciences).
BCR-Induced Calcium Flux
Purified CD23
+ follicular B cells were incubated in culture
medium containing 5 mM Fluo-4/AM (Molecular probes) at 37uC
for 30min. Cells were stimulated with 0.2 mg/ml NP15-BSA and
Fluo-4 fluorescence was measured continuously by flow cytometry
using a LSR (Becton Dickinson).
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